Newsfeeds Archive - Spark Newswire

4 minute read

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

June 20, 1:26 PM

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday’s session following third-quarter results. Jabil reported third-quarter fiscal 2024…

ALUR

2 minute read

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

June 20, 8:22 AM

Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today’s pre-market trading after the company disclosed a strategic partnership…

ASLN

2 minute read

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor

June 20, 5:29 AM

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday. Shares…

ARQT

2 minute read

Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday

By Avi Kapoor

June 13, 10:17 AM

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Tesla…

ACLS

3 minute read

Uncategorized

S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat

By Avi Kapoor

June 6, 2:45 PM

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.1% on Thursday.…

ASNS

4 minute read

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Avi Kapoor

June 6, 1:39 PM

Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday’s session after the company reported worse-than-expected quarterly…

AEMD

3 minute read

Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings

By Avi Kapoor

June 6, 12:22 PM

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Thursday.…

ASNS

1 minute read

Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal

By Vandana Singh

June 6, 12:13 PM

Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurological conditions.

VNDA

2 minute read

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor

May 9, 5:49 AM

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares…

ABNB

1 minute read

Vanda Pharmaceuticals Confirms Receipt Of Revised Unsolicited Takeover Proposal From Future Pak; Says ‘Co Does Not Intend To Comment Further On The Revised, Unsolicited Proposal Before The Board Has Completed Its Review’

By Benzinga Newsdesk

May 7, 11:18 AM

No Shareholder Action Required at This TimeWASHINGTON, May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA) today confirmed that it has received a revised unsolicited proposal

VNDA